These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 35545027)

  • 41. Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine.
    Furuyama W; Shifflett K; Pinski AN; Griffin AJ; Feldmann F; Okumura A; Gourdine T; Jankeel A; Lovaglio J; Hanley PW; Thomas T; Clancy CS; Messaoudi I; O'Donnell KL; Marzi A
    mBio; 2022 Feb; 13(1):e0337921. PubMed ID: 35012339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Human Nose Organoid Respiratory Virus Model: an
    Rajan A; Weaver AM; Aloisio GM; Jelinski J; Johnson HL; Venable SF; McBride T; Aideyan L; Piedra FA; Ye X; Melicoff-Portillo E; Yerramilli MRK; Zeng XL; Mancini MA; Stossi F; Maresso AW; Kotkar SA; Estes MK; Blutt S; Avadhanula V; Piedra PA
    mBio; 2021 Feb; 13(1):e0351121. PubMed ID: 35164569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of systemic, mucosal, and cellular immunity against SARS-CoV-2 in mice vaccinated by trans-airway with a S1 protein combined with a pulmonary surfactant-derived adjuvant SF-10.
    Kimoto T; Sakai S; Kameda K; Morita R; Takahashi E; Shinohara Y; Kido H
    Influenza Other Respir Viruses; 2023 Mar; 17(3):e13119. PubMed ID: 36909295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pulmonary innate immune response in Sars-cov-2 infection].
    Bottino E; Ponce AA
    Rev Fac Cien Med Univ Nac Cordoba; 2022 Mar; 79(1):33-42. PubMed ID: 35312259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
    Americo JL; Cotter CA; Earl PL; Liu R; Moss B
    Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2202069119. PubMed ID: 35679343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunopathogenesis and immunobiology of SARS-CoV-2.
    Rabaan AA; Al-Ahmed SH; Al Mutair A; Alhumaid S; Sule AA; Tirupathi R; Fawzy M; Muhammad J; Khan A; Hasan A; Shrestha DB; Sah R; Dhawan M; Tiwari R; Bilal M; Ahmad T; Dhama K
    Infez Med; 2021 Jun; 29(2):167-180. PubMed ID: 34061781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).
    Lotfi R; Kalmarzi RN; Roghani SA
    Immunol Res; 2021 Jun; 69(3):213-224. PubMed ID: 33928531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
    Schijns V; Lavelle EC
    Eur J Immunol; 2020 Jul; 50(7):932-938. PubMed ID: 32438473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intranasal COVID-19 vaccines: From bench to bed.
    Alu A; Chen L; Lei H; Wei Y; Tian X; Wei X
    EBioMedicine; 2022 Feb; 76():103841. PubMed ID: 35085851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-CoV-2 proteins and mRNA vaccines.
    Boley PA; Lee CM; Schrock J; Yadav KK; Patil V; Suresh R; Lu S; Feng MM; Hanson J; Channappanavar R; Kenney SP; Renukaradhya GJ
    J Nanobiotechnology; 2023 Feb; 21(1):60. PubMed ID: 36814238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Immunopathobiology of SARS-CoV-2 Infection.
    Patel M; Shahjin F; Cohen JD; Hasan M; Machhi J; Chugh H; Singh S; Das S; Kulkarni TA; Herskovitz J; Meigs DD; Chandra R; Hettie KS; Mosley RL; Kevadiya BD; Gendelman HE
    FEMS Microbiol Rev; 2021 Nov; 45(6):. PubMed ID: 34160586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
    Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
    Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
    Cheetham NJ; Kibble M; Wong A; Silverwood RJ; Knuppel A; Williams DM; Hamilton OKL; Lee PH; Bridger Staatz C; Di Gessa G; Zhu J; Katikireddi SV; Ploubidis GB; Thompson EJ; Bowyer RCE; Zhang X; Abbasian G; Garcia MP; Hart D; Seow J; Graham C; Kouphou N; Acors S; Malim MH; Mitchell RE; Northstone K; Major-Smith D; Matthews S; Breeze T; Crawford M; Molloy L; Kwong ASF; Doores K; Chaturvedi N; Duncan EL; Timpson NJ; Steves CJ
    Elife; 2023 Jan; 12():. PubMed ID: 36692910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines.
    Epsi NJ; Richard SA; Lindholm DA; Mende K; Ganesan A; Huprikar N; Lalani T; Fries AC; Maves RC; Colombo RE; Larson DT; Smith A; Chi SW; Maldonado CJ; Ewers EC; Jones MU; Berjohn CM; Libraty DH; Edwards MS; English C; Rozman JS; Mody RM; Colombo CJ; Samuels EC; Nwachukwu P; Tso MS; Scher AI; Byrne C; Rusiecki J; Simons MP; Tribble D; Broder CC; Agan BK; Burgess TH; Laing ED; Pollett SD;
    Clin Infect Dis; 2023 Feb; 76(3):e439-e449. PubMed ID: 35608504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mathematical modeling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis.
    Du SQ; Yuan W
    J Med Virol; 2020 Sep; 92(9):1615-1628. PubMed ID: 32356908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Viral-vectored respiratory mucosal vaccine strategies.
    Jeyanathan M; Afkhami S; Kang A; Xing Z
    Curr Opin Immunol; 2023 Oct; 84():102370. PubMed ID: 37499279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination.
    Qi F; Cao Y; Zhang S; Zhang Z
    Front Immunol; 2022; 13():964976. PubMed ID: 36119105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of Broadly Reactive Responses in Patients With MERS-CoV Infection and SARS-CoV-2 Vaccination.
    Zedan HT; Smatti MK; Thomas S; Nasrallah GK; Afifi NM; Hssain AA; Abu Raddad LJ; Coyle PV; Grivel JC; Almaslamani MA; Althani AA; Yassine HM
    JAMA Netw Open; 2023 Jun; 6(6):e2319222. PubMed ID: 37389876
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Putative Role of Vitamin D for COVID-19 Vaccination.
    Chiu SK; Tsai KW; Wu CC; Zheng CM; Yang CH; Hu WC; Hou YC; Lu KC; Chao YC
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Obesity Is Associated with an Impaired Baseline Repertoire of Anti-Influenza Virus Antibodies.
    Abd Alhadi M; Friedman LM; Karlsson EA; Cohen-Lavi L; Burkovitz A; Schultz-Cherry S; Noah TL; Weir SS; Shulman LM; Beck MA; Hertz T
    Microbiol Spectr; 2023 Jun; 11(3):e0001023. PubMed ID: 37098954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.